GlassScriptPhysician profile
Lori L Krueger
NPI 1497721484
$1,501.06
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $188 · 2020: $141 · 2021: $360 · 2022: $376 · 2023: $306 · 2024: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $436.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $436.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $258.55 | 2019-2022 | |
| Sight Sciences, INC. | $251.45 | 2022-2023 | Tearcare System |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $225.70 | 2021 | |
| Novartis Pharmaceuticals Corporation | $138.23 | 2019-2022 | |
| Abbvie INC. | $113.45 | 2022-2024 | |
| Biotissue Holdings INC. | $107.59 | 2022 | |
| Medline Industries LP | $105.40 | 2023-2024 | |
| Coopervision INC. | $77.07 | 2019-2024 | Myday Contact Lens |
| Shire North American Group INC | $57.15 | 2019 | |
| Bausch & Lomb Americas INC. | $51.36 | 2022-2024 | Miebo, Infuse |
| Sun Pharmaceutical Industries INC. | $42.63 | 2019-2022 | |
| Johnson & Johnson Vision Care, INC. | $31.77 | 2020-2021 | |
| Tarsus Pharmaceuticals, INC. | $21.06 | 2024 | Xdemvy |
| Carl Zeiss Meditec USA, INC. | $19.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Krueger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.